Pseudomonas aeruginosa polymicrobial interactions during lung infection.
Karishma Bisht1, Jiwasmika Baishya1, Catherine A Wakeman1
1Texas Tech University, Department of Biological Sciences, Lubbock TX, USA.
Current Opinion in Microbiology
|February 17, 2020
Summary
Chronic infections involve complex microbial communities, not just single pathogens. Understanding these polymicrobial interactions is key to developing new treatments for persistent diseases like those caused by Pseudomonas aeruginosa.
Area of Science:
- Microbiology
- Infectious Diseases
- Bacterial Pathogenesis
Background:
- Chronic infections frequently harbor diverse microbial communities that resist antibiotic therapies.
- Traditionally, pathogens like Pseudomonas aeruginosa are studied in isolation, overlooking their interactions within polymicrobial environments.
- Emerging research highlights the significance of microbial interactions in determining chronic infection outcomes.
Purpose of the Study:
- To emphasize the necessity of studying polymicrobial communities in chronic infections.
- To underscore the role of interactions between microbes, including Pseudomonas aeruginosa, in disease progression.
- To advocate for a shift from single-species studies to community-focused approaches for better therapeutic strategies.
Main Methods:
- Review of current literature on chronic polymicrobial infections.
- Analysis of Pseudomonas aeruginosa colonization in chronic lung diseases.
- Examination of microbial interaction dynamics (antagonistic and synergistic) in infectious contexts.
Main Results:
- Pseudomonas aeruginosa can persist for years in chronic lung infections, interacting with various microbes (bacteria, fungi, viruses).
- Microbial interactions are context-dependent, ranging from beneficial to detrimental.
- Focusing solely on individual pathogens provides an incomplete picture of chronic infection physiology.
Conclusions:
- Chronic infections are complex ecosystems requiring a community-based understanding.
- Interactions within polymicrobial communities significantly influence infection dynamics and host response.
- Future research and therapeutic development for persistent infections should prioritize the entire microbial community, not just individual species.
More Related Videos
Related Concept Videos
01:30Pneumonia I: Introduction
653
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
653
01:28Gene Regulation in Microbial Communities: Quorum Sensing
423
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
423
01:27Combined Effects of Drugs: Synergism
6.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.6K
01:29Pneumonia II: Pathophysiology
2.4K
The pathophysiology of pneumonia involves the following steps:
2.4K
01:30Pneumonia III: Complications and Assessment
718
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
718
01:28Pneumonia IV: Management
685
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
685